Recombinant TGF-β1 stimulates bone marrow osteoprogenitor cell activity and bone matrix synthesis in osteopenic, old male mice

Journal of Cellular Biochemistry

Volumn 73, Issue 3, 1999, Pages 379-389

  Gazit, Dan ^a   Zilberman, Yoram ^a   Turgeman, Cadi ^a   Zhou, Shuanhu ^a   Kahn, Arnold ^b,c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone formation; Marrow osteoprogenitor; Old mice; Osteopenia; TGF

Indexed keywords

ALKALINE PHOSPHATASE; GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE MATRIX; ENZYME ACTIVITY; FRACTURE HEALING; HYPOTHESIS; MOUSE; NONHUMAN; OSSIFICATION; OSTEOPENIA; PRIORITY JOURNAL; STEM CELL; SYNTHESIS; AGE; ANIMAL; BAGG ALBINO MOUSE; BONE MARROW CELL; CELL CULTURE; CELL DIVISION; COMPARATIVE STUDY; FEMUR; HISTOLOGY; MALE; METABOLIC BONE DISEASE; METABOLISM; PHYSIOLOGY; RIB; TIBIA;

AGE FACTORS; ALKALINE PHOSPHATASE; ANIMALS; BONE DISEASES, METABOLIC; BONE MARROW CELLS; BONE MATRIX; CELL DIVISION; CELLS, CULTURED; FEMUR; FRACTURE HEALING; MALE; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; RIBS; STEM CELLS; TIBIA; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033145647     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19990601)73:3<379::AID-JCB9>3.0.CO;2-U     Document Type: Article

References (65)

1. Aspenberg P, Jeppson C, Wang JS, Boatorm M. 1996. Transforming growth factor beta and bone morphogenetic protein 2 for bone ingrowth: A comparison using bone chambers in rats. Bone 19:499-503.
2. Amsterdam A, Keren-Tal I, Aharoni D. 1996. Cross-talk between cAMP and p53-generated signals in induction of differentiation and apoptosis in steroidogenic granulosa cells. Steroids 61:252-256.
3. Amsterdam A, Dantes A, Selvarage N, Aharoni D. 1997. Apoptosis in steroidogenic cells: Structure-function analysis. Steroids 62:207-211.
4. Bai S, Bailey MC, Celino DL, Lantry MM, Edwards MW. 1993. High-dose estrogen inhibits bone resorption and stimulates bone formation in the ovariectomized mouse. J Bone Miner Res 11:435-442.
5. Beaudreuil J, Mbalaviele G, Cohen-Solal M, Morieux C, DeVernejoul MC, Orcel P. 1995. Short term local injections of transforming growth factor-β1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats. J Bone Miner Res 10:971-977.
6. Beresford JN, Joyner CJ, Delvin CJT, Triffitt JT. 1994. The effects of dexamethasone and 1,25-dihydroxyvitamin D3 on osteogenic differentiation of human marrow stromal cells in vitro. Arch Oral Biol 39:941-947.
7. Bergman RJ, Gazit D, Kahn A, Gruber H, Dougal S, Hahn TJ. 1995. Age-related changes in osteogenic stem cells in mice. J Bone Min Res 11:568-577.
8. Bonewald LF, Dallas SL. 1994. Role of active and latent transforming growth factor β in bone formation. J Cell Biochem 55:350-357.
9. Bonewald LF, Mundy GR. 1990. Role of transforming growth factor-beta in bone remodeling. Clin Orthop Relat Res 250:261-276.
10. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
11. Bruder SC, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
12. Carlino JA, Higley HR, Creson JR, Avis PD, Ogawa Y, Ellingsworth LR. 1992. Transforming growth factor β1 systemically modulates granuloid, erythroid, lymphoid, and thrombocytic cells in mice. Exp Hematol 20:943-950.
13. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. 1994. Transforming growth factor-β gene family members and bone. Endocrinol Rev 15:27-39.
14. Cheng S, Yang JW, Rifas L, Zhang S, Avioli LV. 1994. Differentiation of human bone marrow osteogenic stromal cell in vitro. Induction of osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
15. Critchlow MA, Bland YS, Ashhurst DE. 1995. The expression of collagen mRNAs in normally developing neonatal rabbit long bones and after treatment of neonatal and adult rabbit tibiae with transforming growth factor-β2. Histochem J 27:505-515.
16. Eastell R, Delmas PD, Hodgson SF, Erikson EF, Mann KG, Riggs BL. 1988. Bone formation rate in older normal woman: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67:741-748.
17. Erlebacher A, Filvaroff EH, Giltelman SE, Derynck R. 1995. Towards a molecular understanding of skeletal development. Cell 80:371-378.
18. Erlebacher A, Derynck R. 1996. Increased expression of TGF-β2 in osteoblast results in an osteoporosis-like phenotype. J Cell Biol 132:195-210.
19. Erlebacher A, Filvaroff, EH, Ye, J-Q, Derynck, R. 1998. Osteoblastic responses to TGF-β during bone remodeling. Mol Biol Cell 9:1903-1918.
20. Finkelman RD, Bell NH, Strong DD, Demers LM, Baylink DJ. 1992. Ovariectomy selectively reduces the concentration of transforming growth factor β in rat bone: Implications for estrogen deficiency-associated bone loss. Proc NatlAcad Sci USA 98:12190-12193.
21. Friedenstein AJ, Petrakova KV, Kuralesova AI, Frolova GP. 1968. Heterotopic transplants of bone marrow: Analysis of precursor cells for osteogenic and hemopoietic tissues. Transplantation 6:230-240.
22. Friedenstein AJ, Chilakhyan PK, Latzinik NV, Panasynk AF, Kelilis-Borok IV. 1974. Stromal cells responsible for transferring the micronenvironment of hemopoietic tissues. Cloning in-vitro and retransplantation in-vivo. Transplantation 17:331-340.
23. Friedenstein AJ. 1976. Precursor cells of mechanocytes. Int Rev Cytol 47:327-355.
24. Gazit D, Ebner R, Kahn AJ, Derynck R. 1993. Modulation of expression and cell surface binding of members of the transforming growth factor-β superfamily during retinoid acid-induced osteoblastic differentiation of multipotential mesenchymal cells. Mol Endocrinol 7:189-198.
25. Gazit D, Zilberman Y, Ebner R, Kahn A. 1998. Bone loss (osteopenia) in old, male mice results from the diminished activity and availability of TGF-β. J Cell Biochem 70:478-488.
26. Gazit D, Zilberman Y, Passi-Even L, Ebner R, Kahn AJ. 1995. In vivo administration of TGF-betal increases marrow osteoprogenitor number and selectively reverses the bone loss seen in old "osteoporotic" mice. J Bone Miner Res [Suppl. 1] 10:S145, 25.
27. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. 1995. Fas ligand-induced apoptosis as a mechanism of immune privelege. Science 270:1189-1192.
28. Grills BL, Schuigers JA, Ward AR. 1997. Topical application of nerve growth factor improves fracture healing in rats. J Orthop Res 15:235-242.
29. Harris, SE, Bonewald LF, Harris MA, Sabatini M, Dallas, Feng JQ, Ghosh-Choudhury N, Wozney, Mundy GR. 1994. Effects of transforming growth factor β on bone nodule formation and expression of bone morphogenetic protein 2, osteocalcin, osteopontin, alkaline phosphatase, and type I collagen mRNA in long-term cultures of fetal rat calvarial osteoblasts. J Bone Miner Res 855-863.
30. Hestdal K, Jacobsen SEW, Ruscetti FW, Longo DL, Boone TC, Keller JR. 1993. Increased granulopoiesis after sequential administration of transforming growth factor β-1 and granulocyte-macrophage colony-stimulating factor. Exp Hematol 21:799-805.
31. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF. 1996. Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-β. Nature Med 2:1132-1136.
32. Inoue K, Ohgushi H, Yoshikawa T, Okumura M, Sempuku T, Tamai S, Dohi Y. 1997. The effects of aging on bone formation in porous hydroxyapatite: Biochemical and histological analysis. J Bone Miner Res 12:989-994.
33. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. 1997. Osteogenic differentiation of purified culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312.
34. Jennings J, Mohan C, Linkhart S, Widstrom TA, Baylink DJ. 1988. Comparison of the biological actions of TGF beta-1 and TGF beta-2: Differential activity in endothelial cells. J Cell Physiol 137:167-172.
35. Kahn A, Gibbons R, Perkins S, Gazit D. 1995. Age-related bone loss: A hypothesis and initial assessment in mice. Clin Orthop 313:69-75.
36. Keren-Tal I, Suh BS, Dantes A, Lindner S, Oren M, Amsterdam A. 1995. Involvement of p53 expression in cAMP-mediated apoptosis in immortalized granulosa cells. Exp Cell Res 218:283-295.
37. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RVB, Rowe DW, Robey PG. 1997. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63: 1059-1069.
38. Lawrence DA, Pircher R, Jullien P. 1985. Conversion of a high molecular weight latent TGF-β from chicken embryo flbroblast into a low molecular weight active β-TGF under acidic conditions. Biochem Biophys Res Comm 133:1026-1034.
39. Leboy PS, Beresford JN, Devlin C, Owen ME. 1991. Dexamethasone induction of osteoblasts mRNAs in rat marrow stromal cell cultures. J Cell Physiol 147:111-120.
40. Machwate M, Zerath E, Holy X, Hott M, Godet D, Lomri A, Marie PJ. 1995. Systemic administration of transforming growth factor-β2 prevents the impaired bone formation and osteopenia induced by unloading in rats. J Bone Miner Res [Suppl. 1] 10:S176,152.
41. Manolagas SC, Jilka RL. 1995. Bone marrow, cytokines, and bone remodeling. Emerging insights into pathophysiology of osteoporosis. New Engl J Med 332:305-311.
42. Martin SJ, Reutelingsperger CPM, McGahon AJ, Rader JA, Schie RCAA, LaFace DM, Green DR. 1995. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpression of Bcl-2 and Ab1. J Exp Med 182:1545-1556.
43. Matsushita M, Tosuboyama T, Kasai R. 1986. Age-related changes in bone mass in the senescence-accelerated mouse (SAM): Sam-R/3 and SAM-P/6 as new murine model for senile osteoporosis. Am J Pathol 125:276-283.
44. Mundy GR, Bonewald LF. 1992. Transforming growth factor beta. In: Gowen M, editor. Cytokines and bone metobolism. Boca Raton, FL: CRC Press, Inc. p 93-107.
45. Nakase T, Nomura S, Yoshikawa H, Hoshimoto J, Hirota S, Kitamura Y, Oikawa S, Ono K, Takaoka K. 1994. Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healing. J Bone Miner Res 9:651-659.
46. Nicolas V, Mohan S, Honda Y, Prewett A, Finkelman RD, Baylink DJ, Parley JR. 1995. An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone. Cal Tissue Int 57:206-212.
47. Nicolas V, Prewett A, Bettica, P, Mohan S, Finkelman RD, Baylink DJ, Farley JR. 1994. Age-related decreases in insulin-like growth factor-I and transforming growth factor-β in femoral cortical bone from both men and women: Implications for bone loss in aging. J Clin Endocrinol Metab 78:1011-1016.
48. Nordin BE, Need AG, Bridges A, Horowitz A. 1992. Relative contributions of years since menopause, age, and weight to vertebral density in post menopausal women. J Clin Endocrinol Metab 74:20-23.
49. Owen M. 1988. Marrow stromal stem cells. J Cell Sci 10:61-76.
50. Owen M, Friedenstein AJ. 1988. Stromal stem cells: Marrow derived osteogenic precursors. Ciba Found Symposium 136:42-53.
51. Pollak C, Arnaud E, Reiner D, Marie PJ. 1997. Age-related changes in bone formation, osteoblastic cell proliferation, and differentiation during postnatal osteogenesis in human calvaria. J Cell Biochem 64:128-139.
52. Prockop DJ. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276:71-74.
53. Quarto R, Thomas D, Liang CT. 1995. Bone progenitor cell deficits and the age-associated decline in bone repair capacity. Cal Tissue Int 65:123-129.
54. Rickard DJ, Sullivan TA, Shenker BJ, Leboy PS, Kazhdan I. 1994. Induction of rapid osteoblast differentiation in rat bone marrow stromal cell cultures by dexamethasone and BMP-2. Dev Biol 161:218-228.
55. Roholl PJK, Blauw E, Zurcher C, Dormans JAMA, Theuns HM. 1994. Evidence for the diminished maturation of preosteoblasts into osteoblasts during aging in rats: An ultrastructural analysis. J Bone Miner Res 9:355-366.
56. Rosen D, Miller C, DeLeon E, Thompson AY, Bentz H, Mathew M, Adams S. 1994. Systemic administration of Recombinant Transforming Growth Factor Beta (rTGF-β2) stimulates parameters of cancellous bone formation in juvenile and adult rats. Bone 15:355-359.
57. Rubin CT, Gross TS, Mcleod KJ, Bain SD. 1995. Morphologic stages in lamellar bone formation stimulated by a potent mechanical stimulus. J Bone Miner Res 10:488-495.
58. Shull MM, Ormbsy I, Kier AB, Pawlowski S, Diebold FJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, Annunziata N, Doetschman T. 1992. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature 359:693-699.
59. Siegel S. 1956. Nonparametric statistics for the behavioral sciences. New York: McGraw-Hill.
60. Simmons DJ. 1996. The in vivo role of bone marrow fibroblast-like stromal cells. Cal Tissue Int 58:129-132.
61. Tsuji T, Hughes FJ, McCulloch CAG, Melcher AH. 1990. Effects of donor age on osteogenic cells of rat bone marrow in vitro. Mech Aging Dev 51:121-132.
62. Wang, XF, Lin, HY, Ng-Eaton, E, Downward J, Lodish HF, Weinberg RA. 1991. Expression cloning and characterization of the TGF-β type III receptor. Cell 67:797-805.
63. Westerlind KC, Turner RT. 1995. The skeletal effects of spaceflight in growing rats: Tissue specific alterations in mRNA levels for TGFβ. J Bone Miner Res 10:843-848.
64. Zeng G, McCue HM, Mastrangelo L, Millis AJT. 1996. Endogenous TGF-b activity is modified during cellular aging: Effects on metalloproteinase and TIMP-1 expression. Exp Cell Res 228:271-276.
65. Zhang RW, Supowit SC, Xu X, Li H, Christensen MD, Lozano R, Simmons DJ. 1995. Expression of selected osteogenic markers in the fibroblast-like cells of rat marrow stroma. Cal Tissue Int 56:283-291.